5 questions answered from cited research · Plain language
Anti-VEGF injections for AMD block abnormal blood vessel growth but may also activate immune pathways, including T-cell and inflammatory signals, which could affect long-term outcomes.
Read the full answer →Yes, Eylea HD (aflibercept) is FDA-approved to treat neovascular (wet) age-related macular degeneration (nAMD).
Read the full answer →Yes, combining radiotherapy with anti-VEGF therapy increases the risk of vision loss compared to anti-VEGF alone, based on systematic reviews.
Read the full answer →Yes, aflibercept biosimilars are as safe and effective as the original drug for neovascular AMD, based on a meta-analysis of 11 studies.
Read the full answer →Yes, Pavblu (aflibercept) is FDA-approved specifically for neovascular AMD, so it can treat your condition.
Read the full answer →